Colton Jones, MD, the lead researcher and a hematology and medical oncology fellow at the University of Texas at San Antonio, and colleagues analyzed the health records of nearly 8,800 people with breast cancer and obesity taking both hormonal therapy and GLP-1s
It suggests that most patients who complete treatment are satisfied, but its worth reading the actual review content alongside the star rating
You can read the full article at Results from a phase II trial of Tesofensine for obesity treatment are presented
A provider at Coastal IV Therapy and Urgent Care will instruct you how to give yourself the injection
CJC-1295 acts as GHRH analog providing sustained GH release lasting approximately 6 days post-injection
Its molecular structure includes a fatty acid side chain that allows it to bind to albumin in the bloodstream, which extends its half-life dramatically